Results from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine ...
|
CD40.HIVRI.Env combines a humanized anti-CD40 monoclonal
antibody fused with HIV envelope antigens to stimulate DCs through
CD40 and deliver a ... |